Contact information
+44 (0)1865 618296
Research groups
Colleges
James Larkin
PhD FHEA
Project Manager for PRADA trial
Role
I am the Project Manager for PRADA, a clinical trial exploring how antidepressant treatment can be personalised using clinical, demographic, and genetic data. The programme brings together collaborators across the UK and international partner sites, with the aim of developing a decision support tool for use in routine care.
My work focuses on how the trial operates in practice, including coordination across sites, development of recruitment pathways and clinical workflows, and ensuring that the scientific and technical elements translate into a deliverable and robust clinical protocol. A central part of the role is maintaining alignment across a large, multidisciplinary team while fitting around the constraints of real-world research settings.
Experience
My background spans academic research, clinical trials, and industry. Prior to PRADA, I co-founded a University of Oxford spinout developing biomarker-based diagnostics, where I led programme delivery and helped translate early-stage research towards a clinically viable platform.
I have worked on a range of clinical and translational studies, including multi-site trials integrating imaging and molecular data for disease classification and diagnosis. This has involved close collaboration with partners across academia, the NHS, and industry.
Research and interests
My interests span the broad use of data-driven approaches and translation into tools that are usable in clinical practice. I am particularly interested in the challenges of implementing decision support systems within healthcare, and how trial design can support their evaluation and adoption.
Earlier work focused on diagnostic technologies, including imaging and metabolomics, as well as tumour biology. This has led to a broader interest in how different data types can be combined to improve disease classification and clinical decision-making.
Teaching
Alongside this work, I am involved in small-group undergraduate tutorials in biochemistry at Trinity College. I continue to take an interest in teaching and mentoring, particularly in interdisciplinary and translational research.
Key publications
Metabolomic Biomarkers in Blood Samples Identify Cancers in a Mixed Population of Patients with Nonspecific Symptoms.
Journal article
Larkin JR. et al, (2022), Clin Cancer Res, 28, 1651 - 1661
Improving Delineation of True Tumor Volume With Multimodal MRI in a Rat Model of Brain Metastasis.
Journal article
Larkin JR. et al, (2020), Int J Radiat Oncol Biol Phys, 106, 1028 - 1038
Quantitative blood flow measurement in rat brain with multiphase arterial spin labelling magnetic resonance imaging.
Journal article
Larkin JR. et al, (2019), J Cereb Blood Flow Metab, 39, 1557 - 1569
A type 2 biomarker separates relapsing-remitting from secondary progressive multiple sclerosis.
Journal article
Dickens AM. et al, (2014), Neurology, 83, 1492 - 1499
Recent publications
Informed Dictionary-Guided Monte Carlo Inversion for Robust and Reproducible Multidimensional MRI.
Journal article
Park JS. et al, (2026), Magn Reson Med, 95, 2947 - 2962
Diffusion skewness imaging using Q-space trajectory imaging with positivity constraints.
Journal article
Li J. et al, (2026), Phys Med Biol, 71
Integrating NMR Metabolomics and Glycomics for Early Cancer Detection in Patients with Non-Specific Symptoms
Preprint
Kacerova T. et al, (2026)
